Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40012152
Localisation
Japan
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
21/07/2021
Statut
Classification
1.5°C
Année cible
FY2030
Santen Pharmaceutical Co. , Ltd. commits to reduce absolute scope 1 and 2 GHG emissions 50% by FY 2030 from a FY 2019 base year. Santen Pharmaceutical Co. , Ltd. also commits to reduce absolute scope 3 GHG emissions from purchased goods and services 15% within the same timeframe.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
JP3336000009
LEI
529900TPT3I7C17MIM03
Source : Science Based Targets initiative | Données publiques